肺动脉内膜剥脱术围术期体外膜氧合支持:英国国家队列17年经验
该研究回顾性分析了2005年8月至2022年7月单中心110例(4.7%)因围术期严重心肺功能障碍接受ECMO支持的肺动脉内膜剥脱术患者,62例(56.4%)成功脱离ECMO,57例存活出院(挽救率51.8%),出院存活者5年和10年生存率分别为73.9%(SE: 6.1%)和58.2%(SE: 9.5%)。
要点
- 围术期ECMO可作为肺动脉内膜剥脱术严重心肺并发症的挽救治疗。
- 110例(4.7%)需围术期ECMO,56.4%成功脱机,51.8%存活出院。
- 出院存活者5年生存率73.9%(SE: 6.1%),10年生存率58.2%(SE: 9.5%)。
核心结论
- 围术期ECMO支持作为该组患者的挽救治疗具有适当作用,超过50%存活出院,且这些患者长期生存令人满意。
研究设计与样本
- 回顾性分析2005年8月至2022年7月单国家中心因肺动脉内膜剥脱术接受围术期ECMO的患者,数据前瞻性收集。
主要发现
- 110例(4.7%)出现需围术期ECMO的极度心肺功能障碍。
- 9例在肺动脉内膜剥脱术前建立ECMO。
- 术后接受ECMO者中,39例为难治性再灌注肺损伤,20例为右心室衰竭,31例为支气管内出血,其余11例为其他原因(如晚期心脏压塞后心肺复苏和吸入性肺炎)。
- 62例(56.4%)成功脱离ECMO。
- 57例存活出院,挽救率为51.8%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary endarterectomy (PEA) is the guideline-recommended treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, some patients develop severe cardiopulmonary compromise before surgery, intraoperatively, or early postoperatively. This may result from advanced CTEPH, reperfusion pulmonary edema, massive endobronchial bleeding, or right ventricular (RV) failure secondary to residual pulmonary hypertension. Conventional cardiorespiratory support is ineffective when these complications are severe. Since 2005, we used extracorporeal membrane oxygenation (ECMO) as a rescue therapy for this group. We review our experience with ECMO support in these patients. METHODS: This study was a retrospective analysis of patients who received perioperative ECMO for PEA from a single national center from August 2005 to July 2022. Data were prospectively collected. RESULTS: One hundred and ten patients (4.7%) had extreme cardiorespiratory compromise requiring perioperative ECMO. Nine were established on ECMO before PEA. Of those who received ECMO postoperatively, 39 were for refractory reperfusion lung injury, 20 for RV failure, 31 for endobronchial bleeding, and the remaining 11 were for "other" reasons, such as cardiopulmonary resuscitation following late tamponade and aspiration pneumonitis. Sixty-two (56.4%) were successfully weaned from ECMO. Fifty-seven patients left the hospital alive, giving a salvage rate of 51.8%. Distal disease (Jamieson Type III) and significant residual pulmonary hypertension were also predictors of mortality on ECMO support. Overall, 5- and 10-year survival in patients who were discharged alive following ECMO support was 73.9% (SE: 6.1%) and 58.2% (SE: 9.5%), respectively. CONCLUSIONS: Perioperative ECMO support has an appropriate role as rescue therapy for this group. Over 50% survived to hospital discharge. These patients had satisfactory longer-term survival.
引用
- Chia AXF, Valchanov K, Ng C, et al. Perioperative extracorporeal membrane oxygenation support for pulmonary endarterectomy: A 17-year experience from the UK national cohort. J Heart Lung Transplant. 2023. PMID: 37730188. doi:10.1016/j.healun.2023.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。